Cytoprotective effect of ulinastatin on LLC-PK1 cells treated with antimycin a, gentamicin, and cisplatin

Nephron

Volumn 76, Issue 3, 1997, Pages 300-306

  Ishibashi, Masaaki ^a   Yamasaki, Fumiaki ^a   Nakakuki, Masanori ^a   Shinkawa, Tomoaki ^a   Mizota, Masahiro ^a  

^a MOCHIDA PHARMACEUTICAL CO   (Japan)

Author keywords

Antimycin A; Cisplatin; Gentamicin; LLC PK1 cells; Nephrotoxicity; Ulinastatin

Indexed keywords

ANTIMYCIN A1; BOVINE SERUM ALBUMIN; CISPLATIN; GENTAMICIN; LACTATE DEHYDROGENASE; OROSOMUCOID; SERINE PROTEINASE INHIBITOR; ULINASTATIN;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL PROTECTION; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME RELEASE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ACETYLGLUCOSAMINIDASE; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMYCIN A; ANTINEOPLASTIC AGENTS; CATTLE; CELL DIVISION; CISPLATIN; GAMMA-GLUTAMYLTRANSFERASE; GENTAMICINS; GLYCOPROTEINS; KIDNEY; L-LACTATE DEHYDROGENASE; LLC-PK1 CELLS; OROSOMUCOID; PROTEASE INHIBITORS; PROTEIN BIOSYNTHESIS; SERUM ALBUMIN, BOVINE; SWINE;

EID: 0030751157     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190195     Document Type: Article

References (32)

1. Kosuzume K, Ashida Y, Takemura M, Kato K, Ohnishi H: Mechanisms of enzyme inhibition by trypsin inhibitor in human urine (in Japanese), IgakuNoAyumi 1983:125:187-190.
2. Goda K, Kato K, Nagao Y, Oka T: Mechanism of the anti-osteoarthrilic action of ulinastatin in comparison with those of indomethacin and triamcinolone (English abstract), Folia Pharmacol Jpn 1992:99:93-107.
3. Balduyek M, Laroui S, Mizon C, Mizon J: A proteoglycan related to the urinary try psin inhibitor (UTI) links the two heavy chains of int-er-a-trypsin inhibitor, Biol Chem Hoppe Sevier 1989:370:329-336.
4. Umeki S, Tsukiyama K, Okimoto N, Soejima R: Urinastatin (Kunitz-type proteinase inhibitor) reducing cisplalin nephrotoxicity, Am J Med Sci 1989;298:221-226.
5. Ishigami M, Eguchi M, Yabuki S: Beneficial effects of the urinary trypsin inhibitor urinastatin on renal insults induced by gentamicin and mercuric chloride (HgCL) poisoning, Nephron 1991:58:300-305.
6. Kihara K, Nagata N, Takasaki M: Protective effect of urinastatin on ischemic renal injury in rabbits (English abstract), Jpn J Nephrol 1991; 33:673-677.
7. Kobayashi H, Ohi H, Terao T: Prevention by urinastatin of cis-diamminedichloroplatinum-induccd nephrotoxicity in rabbits: Comparison of urinary enzyme excretions and morphological alterations by electron microscopy, Asia Oceania J Obstet Gynaecol 1991:17:277-288.
8. Yamasaki F, Ishibashi M; Nakakuki M, Wala-nabe M, Shinkawa T, Mizota M: Protective action of ulinastatin against cisplatin nephrotoxicity in mice and its effect on the lysosomal fragility, Nephron 1996:74:158-167.
9. Miyahara T: Effect of urinary trypsin inhibitor, MR-20. on hemorrhagic shock in dogs (English abstract), Jpn J Ancsthcsiol 1983:32:943-955.
10. Nakahama H, Nakanishi T, Sugita M: Cvto-protcctive effects of ulinastatin against hypoxic injury to LLC-PK cells, Nephron 1994:68: 411-412.
11. Swanson RA: Astrocyte glutamate uptake during chemical hypoxia in vitro, Neurosci Lett 1992:147:143-146.
12. Vcnkatachalam MA, Patel YJ, Kreisberg JI, Weinberg JM: Energy thresholds that determine membrane integrity and injury in a renal epithelial cell line (LLC-PK), J Clin Invest 1988:81:745-758.
13. Canfield PE, Gecrdes AM, Molitoris BA: Effect of reversible ATP depletion on tight-junction integrity in LLC-PK cells, Am J Physiol 1991: 261:F1038-FI045.
14. Kassell B: Bovine trypsin-kallikrein inhibitor: in Perlmann GE, Lorand L (eds): Methods in Enzymology, New York, Academic Press, 1970. vol 19. pp 844-852.
15. Hull RN, Cherry WR, Weaver GW: The origin and characteristics of a pig kidney cell strain, LLC-PK, In vitro 1976:12:670-677.
16. Baldew GS, Boymans AP, Mol JGJ, Vermeul-en NPE: The influence of ebsclen on the toxicity of cisplatin in LLC-PK cells, Biochem Pharmacol 1992:44:382-387.
17. Olbricht CJ, Fink M, Gutjahr E: Alterations in lysosomal enzymes of the proximal tubule in gentamicin nephrotoxicity, Kidney Int 1991: 39:639-646.
18. Aoike I, Takano Y, Gejo F, Arakawa M: Ulinastatin gives rise to an effectual diuresis in oliguric acute renal failure, Nephron 1989:52: 368-369.
19. Bonbentre JV: Mechamsims of ischemic acute renal failure, Nephron 1993:43:1160-1178.
20. Nakajima T, Hishida A, Kato A: Mechanisms of protective effects of free radical scavengers on gentamicin-mediated nephropathy in rats, Am J Physiol !994:266:F425-F431.
21. Sttgihara K, Nakano S, Koda M, Tanaka K, Fukuishi N, Gemba M: Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues, Jpn J Pharmacol 1987:43:247-252.
22. Whittem T, Schnellmann RG, Ferguson DC: Poly-L-aspartic acid does but triiodothyrosine does not protect against gentamicin-induced cytotoxicity in the porcine kidney cell line LLC-PK, J Pharmacol Exp Ther" 1992:262: 834-840.
23. Mori R, Yamamoto K, Saito H, Kohno M, lnui K: Effect of aminoglycoside antibiotics on cellular functions of kidney epithelial cell line (LLC-PK,): A model system for aminoglycoside nephrotoxicity, J Pharmacol Exp Ther 1984;230:742-748.
24. Glass RD, Doyle D: On the measurement of protein turnover in animal cells, J Biol Chem 1972;247:5234-5242.
25. Posen S: Turnover of circulating cnyzmes, Clin Chem 1970:16:71-84.
26. Maack T, Park CH, Camargo MJF: Renal filtration, transport and metabolism of protein: in Seldin DW, Giebisch G (eds): The kidney: Physiology and Pathophysiology, ed 2. New York, Raven Press, 1992. pp 3005-3038.
27. Paller MS, Hoidal JR, Ferris TF: Oxygen free radicals in ischemic acute renal failure in the rat, J Clin Invest 1984:74:1156-1164.
28. Chen Q, Stevens JL: Inhibition of iodoacetam-ide and t-butylhydroperoxide toxicity in LLC-PK, cells by antioxidants: A role for lipid peroxidation in alkvlation induced cytotoxicity, Arch Biochem Biophys 1991:284:422-430.
29. Abe H, Carballo J, Appcrt HE, Howard JM: The release and fate of the intestinal lysosomal enzymes after acute ischemic injury of the intestine, Surg Gvnecol Obstet 1972:135:581-585.
30. Weinberger P, Weinberger A: Lysosomal alterations in ischemic myocardium: Result or cause of myocellular damage? J Mol Cell Cardiol 1978:10:595-603.
31. Laurent G, Kishore BK, Tulkcns PM: Aminoglycoside-induced renal phospholipidosis and nephrotoxicity, Biochem Pharmacol 1990:40: 2383-2392.
32. Nakakuki M, Yamasaki F, Shinkawa T, Kudo M, Watanabe M, Mizota M: Protective effect of human ulinastatin against gentamicin-induced acute renal failure in rats, Can J Physiol Pharmacol 1996;74:104-111.